New recommendations to reduce unnecessary blood tests after robot-assisted radical prostatectomy.

Abstract

Radical prostatectomy (RP) is a standard treatment for men with localised prostate cancer. Robot Assisted Radical Prostatectomy (RARP) is associated with fewer intraoperative adverse events, reduced blood loss and lower complication rates compared to open and laparoscopic surgery but delivers comparable oncological and functional outcomes (1). Furthermore, the use of Enhanced Recovery after Surgery (ERAS) pathways for RARP, have improved patient recovery and experience, reducing costs and maintaining patient safety (2).